UniProtKB/Swiss-Prot Q96RL1: Variant p.Pro435Leu

BRCA1-A complex subunit RAP80
Gene: UIMC1
Feedback?

Variant information Variant position:

435 The position of the amino-acid change on the UniProtKB canonical protein sequence.
Type of variant:

LB/B The variants are classified into three categories: LP/P, LB/B and US.

LP/P: likely pathogenic or pathogenic.
LB/B: likely benign or benign.
US: uncertain significance

Residue change:

From Proline (P) to Leucine (L) at position 435 (P435L, p.Pro435Leu). Indicates the amino acid change of the variant. The one-letter and three-letter codes for amino acids used in UniProtKB/Swiss-Prot are those adopted by the commission on Biochemical Nomenclature of the IUPAC-IUB.
Physico-chemical properties:

Similar physico-chemical property. Both residues are medium size and hydrophobic. The physico-chemical property of the reference and variant residues and the change implicated.
BLOSUM score:

-3 The score within a Blosum matrix for the corresponding wild-type to variant amino acid change. The log-odds score measures the logarithm for the ratio of the likelihood of two amino acids appearing by chance. The Blosum62 substitution matrix is used. This substitution matrix contains scores for all possible exchanges of one amino acid with another:

Lowest score: -4 (low probability of substitution).
Highest score: 11 (high probability of substitution).

More information can be found on the following page
Other resources:

Links to websites of interest for the variant.

Variant rs3733876 [ dbSNP | Ensembl ]

Sequence information Variant position:

435 The position of the amino-acid change on the UniProtKB canonical protein sequence.
Protein sequence length:

719 The length of the canonical sequence.
Location on the sequence:

SVPASQSVAALTSKRSLVLM P ESSAEEITVCPETQLSSSET The residue change on the sequence. Unless the variant is located at the beginning or at the end of the protein sequence, both residues upstream (20) and downstream (20) of the variant will be shown.
Residue conservation:

The multiple alignment of the region surrounding the variant against various orthologous sequences.

Human                         SVPASQSVAALTSKRSLVLMPESSAEEITVCPETQLSSSET

Mouse                         SVPTTQSIAALTSKRSLVLMPESSAEEITVCPETQLSFLEP

Rat                           AVPASQSIAVLTSKRDLVLMPEASTEEVTVCPETQLSSFEP

Pig                           SVPASQSIAALTGKRSSVLMPESSAEEITVCPETQLSSPET

Xenopus tropicalis            QCSHC---------------SESSELDYSVLPNSLQAEPFK

Sequence annotation in neighborhood:

The regions or sites of interest surrounding the variant. In general the features listed are posttranslational modifications, binding sites, enzyme active sites, local secondary structure or other characteristics reported in the cited references. The "Sequence annotation in neighborhood" lines have a fixed format:

Type: the type of sequence feature.
Positions: endpoints of the sequence feature.
Description: contains additional information about the feature.

Type	Positions	Description
Chain	1 – 719	BRCA1-A complex subunit RAP80
Region	400 – 500	Necessary for interaction with NR6A1 C-terminus
Modified residue	419 – 419	Phosphoserine
Cross	428 – 428	Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2)
Alternative sequence	153 – 719	Missing. In isoform 5.

Literature citations
Analysis of the genes coding for the BRCA1-interacting proteins, RAP80 and Abraxas (CCDC98), in high-risk, non-BRCA1/2, multiethnic breast cancer cases.
Novak D.J.; Sabbaghian N.; Maillet P.; Chappuis P.O.; Foulkes W.D.; Tischkowitz M.;
Breast Cancer Res. Treat. 117:453-459(2009)
Cited for: VARIANTS TRP-15; THR-353; LEU-435 AND ARG-511;

Disclaimer: Any medical or genetic information present in this entry is provided for research, educational and informational purposes only. They are not in any way intended to be used as a substitute for professional medical advice, diagnostic, treatment or care.